An Open-label, Randomised, Multicentre, Multi-country Three-arm Study of the Treatment with Finafloxacin 400 mg b.i.d. plus Esomeprazole 40 mg b.i.d. for 14 days versus Finafloxacin 400 mg b.i.d. plus Esomeprazole 40 mg b.i.d. plus Amoxicillin 1000 mg b.i.d. for 10 days versus Clarithromycin 500 mg b.i.d. plus Amoxicillin 1000 mg b.i.d. plus Esomeprazole 40 mg b.i.d. for 10 Days in Patients with Helicobacter pylori infection. Finafloxacin in patients with Helicobacter: The FLASH 2 Study.
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2013
At a glance
- Drugs Amoxicillin; Clarithromycin; Esomeprazole; Finafloxacin
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- Acronyms FLASH2
- 21 Apr 2012 Additional location (Germany) added as reported by European Clinical Trials Database.
- 16 Jun 2011 New trial record